Medindia
Medindia LOGIN REGISTER
Advertisement

Upcoming Beckman Coulter Investor Events Second Half of 2010

Thursday, June 24, 2010 General News
Advertisement
ORANGE COUNTY, Calif., June 23 Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announces upcoming company presentations and investor events. Please mark your calendars accordingly.
Advertisement

(Logo: http://photos.prnewswire.com/prnh/20031202/BECLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

Please refer to the company's website at www.beckmancoulter.com for updates on specific details of time for the company presentations referenced above. To access this information from our site, select "go to IR" under Investor Relations and look for "What's Ahead".
Advertisement

About Beckman Coulter

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of consumable supplies (including reagent test kits), service and operating-type lease payments, represent about 80% of the company's 2009 revenue of $3.3 billion. For more information, visit www.beckmancoulter.com.

-- Q2 2010 Earnings Release scheduled after market close on Monday, August 2, 2010. -- Conference call set for 2:00 p.m. (PT). -- There also will be a live webcast of the call. It will be accessible to all investors through Beckman Coulter's website at www.beckmancoulter.com.

SOURCE Beckman Coulter, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close